IBDEI1JE ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,24876,1,4,0)
;;=4^K08.89
;;^UTILITY(U,$J,358.3,24876,2)
;;=^5008467
;;^UTILITY(U,$J,358.3,24877,0)
;;=B97.89^^85^1095^7
;;^UTILITY(U,$J,358.3,24877,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24877,1,3,0)
;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,24877,1,4,0)
;;=4^B97.89
;;^UTILITY(U,$J,358.3,24877,2)
;;=^5000879
;;^UTILITY(U,$J,358.3,24878,0)
;;=H54.7^^85^1095^8
;;^UTILITY(U,$J,358.3,24878,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24878,1,3,0)
;;=3^Visual Loss,Unspec
;;^UTILITY(U,$J,358.3,24878,1,4,0)
;;=4^H54.7
;;^UTILITY(U,$J,358.3,24878,2)
;;=^5006368
;;^UTILITY(U,$J,358.3,24879,0)
;;=I83.91^^85^1095^5
;;^UTILITY(U,$J,358.3,24879,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24879,1,3,0)
;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
;;^UTILITY(U,$J,358.3,24879,1,4,0)
;;=4^I83.91
;;^UTILITY(U,$J,358.3,24879,2)
;;=^5008020
;;^UTILITY(U,$J,358.3,24880,0)
;;=I83.92^^85^1095^4
;;^UTILITY(U,$J,358.3,24880,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24880,1,3,0)
;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
;;^UTILITY(U,$J,358.3,24880,1,4,0)
;;=4^I83.92
;;^UTILITY(U,$J,358.3,24880,2)
;;=^5008021
;;^UTILITY(U,$J,358.3,24881,0)
;;=I83.93^^85^1095^3
;;^UTILITY(U,$J,358.3,24881,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24881,1,3,0)
;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
;;^UTILITY(U,$J,358.3,24881,1,4,0)
;;=4^I83.93
;;^UTILITY(U,$J,358.3,24881,2)
;;=^5008022
;;^UTILITY(U,$J,358.3,24882,0)
;;=R53.1^^85^1095^9
;;^UTILITY(U,$J,358.3,24882,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24882,1,3,0)
;;=3^Weakness
;;^UTILITY(U,$J,358.3,24882,1,4,0)
;;=4^R53.1
;;^UTILITY(U,$J,358.3,24882,2)
;;=^5019516
;;^UTILITY(U,$J,358.3,24883,0)
;;=R63.4^^85^1095^10
;;^UTILITY(U,$J,358.3,24883,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24883,1,3,0)
;;=3^Weight Loss,Abnormal
;;^UTILITY(U,$J,358.3,24883,1,4,0)
;;=4^R63.4
;;^UTILITY(U,$J,358.3,24883,2)
;;=^5019542
;;^UTILITY(U,$J,358.3,24884,0)
;;=B02.9^^85^1095^11
;;^UTILITY(U,$J,358.3,24884,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24884,1,3,0)
;;=3^Zoster w/o Complications
;;^UTILITY(U,$J,358.3,24884,1,4,0)
;;=4^B02.9
;;^UTILITY(U,$J,358.3,24884,2)
;;=^5000501
;;^UTILITY(U,$J,358.3,24885,0)
;;=I49.3^^85^1095^6
;;^UTILITY(U,$J,358.3,24885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24885,1,3,0)
;;=3^Vetricular Premature Depolarization
;;^UTILITY(U,$J,358.3,24885,1,4,0)
;;=4^I49.3
;;^UTILITY(U,$J,358.3,24885,2)
;;=^5007233
;;^UTILITY(U,$J,358.3,24886,0)
;;=I83.019^^85^1095^2
;;^UTILITY(U,$J,358.3,24886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24886,1,3,0)
;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
;;^UTILITY(U,$J,358.3,24886,1,4,0)
;;=4^I83.019
;;^UTILITY(U,$J,358.3,24886,2)
;;=^5007979
;;^UTILITY(U,$J,358.3,24887,0)
;;=I83.029^^85^1095^1
;;^UTILITY(U,$J,358.3,24887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24887,1,3,0)
;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
;;^UTILITY(U,$J,358.3,24887,1,4,0)
;;=4^I83.029
;;^UTILITY(U,$J,358.3,24887,2)
;;=^5007986
;;^UTILITY(U,$J,358.3,24888,0)
;;=Z01.818^^85^1096^3
;;^UTILITY(U,$J,358.3,24888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24888,1,3,0)
;;=3^Preporcedural Exam NEC
;;^UTILITY(U,$J,358.3,24888,1,4,0)
;;=4^Z01.818
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1JE 3785 printed Apr 09, 2024@21:38:04 Page 2
IBDEI1JE ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,24876,1,4,0)
+2 ;;=4^K08.89
+3 ;;^UTILITY(U,$J,358.3,24876,2)
+4 ;;=^5008467
+5 ;;^UTILITY(U,$J,358.3,24877,0)
+6 ;;=B97.89^^85^1095^7
+7 ;;^UTILITY(U,$J,358.3,24877,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,24877,1,3,0)
+10 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
+11 ;;^UTILITY(U,$J,358.3,24877,1,4,0)
+12 ;;=4^B97.89
+13 ;;^UTILITY(U,$J,358.3,24877,2)
+14 ;;=^5000879
+15 ;;^UTILITY(U,$J,358.3,24878,0)
+16 ;;=H54.7^^85^1095^8
+17 ;;^UTILITY(U,$J,358.3,24878,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,24878,1,3,0)
+20 ;;=3^Visual Loss,Unspec
+21 ;;^UTILITY(U,$J,358.3,24878,1,4,0)
+22 ;;=4^H54.7
+23 ;;^UTILITY(U,$J,358.3,24878,2)
+24 ;;=^5006368
+25 ;;^UTILITY(U,$J,358.3,24879,0)
+26 ;;=I83.91^^85^1095^5
+27 ;;^UTILITY(U,$J,358.3,24879,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,24879,1,3,0)
+30 ;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
+31 ;;^UTILITY(U,$J,358.3,24879,1,4,0)
+32 ;;=4^I83.91
+33 ;;^UTILITY(U,$J,358.3,24879,2)
+34 ;;=^5008020
+35 ;;^UTILITY(U,$J,358.3,24880,0)
+36 ;;=I83.92^^85^1095^4
+37 ;;^UTILITY(U,$J,358.3,24880,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,24880,1,3,0)
+40 ;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
+41 ;;^UTILITY(U,$J,358.3,24880,1,4,0)
+42 ;;=4^I83.92
+43 ;;^UTILITY(U,$J,358.3,24880,2)
+44 ;;=^5008021
+45 ;;^UTILITY(U,$J,358.3,24881,0)
+46 ;;=I83.93^^85^1095^3
+47 ;;^UTILITY(U,$J,358.3,24881,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,24881,1,3,0)
+50 ;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
+51 ;;^UTILITY(U,$J,358.3,24881,1,4,0)
+52 ;;=4^I83.93
+53 ;;^UTILITY(U,$J,358.3,24881,2)
+54 ;;=^5008022
+55 ;;^UTILITY(U,$J,358.3,24882,0)
+56 ;;=R53.1^^85^1095^9
+57 ;;^UTILITY(U,$J,358.3,24882,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,24882,1,3,0)
+60 ;;=3^Weakness
+61 ;;^UTILITY(U,$J,358.3,24882,1,4,0)
+62 ;;=4^R53.1
+63 ;;^UTILITY(U,$J,358.3,24882,2)
+64 ;;=^5019516
+65 ;;^UTILITY(U,$J,358.3,24883,0)
+66 ;;=R63.4^^85^1095^10
+67 ;;^UTILITY(U,$J,358.3,24883,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,24883,1,3,0)
+70 ;;=3^Weight Loss,Abnormal
+71 ;;^UTILITY(U,$J,358.3,24883,1,4,0)
+72 ;;=4^R63.4
+73 ;;^UTILITY(U,$J,358.3,24883,2)
+74 ;;=^5019542
+75 ;;^UTILITY(U,$J,358.3,24884,0)
+76 ;;=B02.9^^85^1095^11
+77 ;;^UTILITY(U,$J,358.3,24884,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,24884,1,3,0)
+80 ;;=3^Zoster w/o Complications
+81 ;;^UTILITY(U,$J,358.3,24884,1,4,0)
+82 ;;=4^B02.9
+83 ;;^UTILITY(U,$J,358.3,24884,2)
+84 ;;=^5000501
+85 ;;^UTILITY(U,$J,358.3,24885,0)
+86 ;;=I49.3^^85^1095^6
+87 ;;^UTILITY(U,$J,358.3,24885,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,24885,1,3,0)
+90 ;;=3^Vetricular Premature Depolarization
+91 ;;^UTILITY(U,$J,358.3,24885,1,4,0)
+92 ;;=4^I49.3
+93 ;;^UTILITY(U,$J,358.3,24885,2)
+94 ;;=^5007233
+95 ;;^UTILITY(U,$J,358.3,24886,0)
+96 ;;=I83.019^^85^1095^2
+97 ;;^UTILITY(U,$J,358.3,24886,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,24886,1,3,0)
+100 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
+101 ;;^UTILITY(U,$J,358.3,24886,1,4,0)
+102 ;;=4^I83.019
+103 ;;^UTILITY(U,$J,358.3,24886,2)
+104 ;;=^5007979
+105 ;;^UTILITY(U,$J,358.3,24887,0)
+106 ;;=I83.029^^85^1095^1
+107 ;;^UTILITY(U,$J,358.3,24887,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,24887,1,3,0)
+110 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
+111 ;;^UTILITY(U,$J,358.3,24887,1,4,0)
+112 ;;=4^I83.029
+113 ;;^UTILITY(U,$J,358.3,24887,2)
+114 ;;=^5007986
+115 ;;^UTILITY(U,$J,358.3,24888,0)
+116 ;;=Z01.818^^85^1096^3
+117 ;;^UTILITY(U,$J,358.3,24888,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,24888,1,3,0)
+120 ;;=3^Preporcedural Exam NEC
+121 ;;^UTILITY(U,$J,358.3,24888,1,4,0)
+122 ;;=4^Z01.818
